Atlas Trials

Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS)

Clinical trial NCT03184935 · SUSPENDED

Trial details

NCT number
NCT03184935
Sponsor
Sclnow Biotechnology Co., Ltd.
Status
SUSPENDED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2026-12-31
Primary completion
2027-06-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.